Introduction
============

The use of bilateral internal thoracic arteries (BITA) in coronary artery bypass grafting (CABG) is becoming increasingly popular, with accumulating evidence of improved graft patency and overall patient survival in left internal thoracic artery (LITA)-to-left anterior descending artery (LAD) anastomosis. However, the use of BITA is still relatively uncommon worldwide \[[@ref1],[@ref2]\], possibly not only because the harvesting and utilization of BITA is time-consuming and technically complex, but also due to variations in coronary anatomy and the degree of coronary artery disease. Depending on the circumstances, anatomical or technical issues may necessitate modifications.

The current literature demonstrates no difference in clinical outcomes between composite and *in situ* graft configurations \[[@ref3]\]; therefore, given the paucity of comparative data and information regarding the long-term outcomes of complex and atypical BITA configurations, we investigated the clinical outcomes of patients who received BITA grafts of various configurations at our institution. We assessed whether BITA configuration impacted survival or patency in patients undergoing CABG and whether any particular configuration was superior with respect to survival or the need for repeat revascularization.

Methods
=======

Patients
--------

Between January 2006 and June 2017, 1,161 consecutive patients underwent CABG with BITA composite grafting at Seoul National University Bundang Hospital. Of those, 160 patients required modifications of the graft configuration and were included in the present study. The composite BITA graft was modified for the following reasons: (1) 75 patients (47%) had a RITA with insufficient length for sequential anastomosis; (2) 45 patients (28%) had intrinsic LITA limitations due to left subclavian artery stenosis, ipsilateral arteriovenous fistula, or LITA injury during harvest; (3) 26 patients (16.3%) had non-triplet coronary disease; and (4) 14 patients (8.7%) exhibited target vessel size mismatch or an unsuitable geometric orientation for sequential anastomosis. From patients' medical records, information was extracted on their demographics, preoperative risk factors, operative technique, postoperative hospital course, imaging data, and clinical outcomes. Data were reviewed retrospectively to investigate technical details, clinical outcomes, and graft patency.

The institutional review board of our institution approved the research design (IRB approval no., B-1909/565-107) and waived the need for informed consent.

Surgical technique
------------------

All patients underwent full median sternotomy. The standard technique at our institution was *in situ* LITA-based Y-composite grafting with the LITA anastomosed to the LAD and the right internal thoracic artery (RITA) sequentially anastomosed to non-LAD targets. The internal thoracic artery (ITA) was mostly harvested in a skeletonized fashion. More than half of the patients underwent off-pump CABG (59.4%), while the remainder underwent on-pump beating-heart or conventional CABG (40.6%) with antegrade cardioplegia due to a low ejection fraction or concomitant procedures.

We divided patients into 3 groups according to the types of modifications made. In group 1, the patients required minor alterations of the typical Y graft ([Fig. 1A--D](#F1){ref-type="fig"}). In these patients, 4 different geometric or anastomotic configurations were identified: ([Fig. 1A](#F1){ref-type="fig"}) a short RITA extended with a remaining segment of the LITA or an additionally-harvested saphenous vein graft, ([Fig. 1B](#F1){ref-type="fig"}) a twisted Y configuration used due to size mismatch between the LITA and the LAD, ([Fig. 1C](#F1){ref-type="fig"}) a secondary Y anastomosis made at the proximal or distal end of the RITA, and ([Fig. 1D](#F1){ref-type="fig"}) a double Y or π configuration used for sequential anastomosis to non-LAD targets on the RITA.

In group 2, the RITA was anastomosed end-to-end to the LITA to create an I-composite graft ([Fig. 1E, F](#F1){ref-type="fig"}) and was then anastomosed sequentially to the LAD or other territories. Finally, in group 3, the RITA was used as an inflow graft ([Fig. 1G--J](#F1){ref-type="fig"}). This group also included 3 different geometric or anastomotic configurations: ([Fig. 1G, H](#F1){ref-type="fig"}) a RITA-based I graft, ([Fig. 1I](#F1){ref-type="fig"}) a RITA-based reverse T graft, and ([Fig. 1J](#F1){ref-type="fig"}) a RITA-based Y graft.

Follow-up
---------

All patients enrolled in the study participated in regular outpatient follow-up. The mean length of follow-up was 51.0±42.5 months (range, 3 days to 140 months). Graft patency was evaluated in a total of 116 patients (72.5%) using computed tomography (CT) coronary angiography (CAG) or conventional CAG with a mean interval of 29.9±31.1 months after CABG surgery. The imaging follow-up protocol at our institution was to perform CT angiography at 9 to 10 months postoperatively and to perform CAG at 5 years postoperatively. We defined graft failure as the total occlusion of the anastomosed graft as revealed on CT angiography during follow-up.

Statistical analysis
--------------------

Preoperative demographic and investigative data, operative variables, 30-day mortality and morbidity, and 5-year survival were compared among the study groups. Categorical variables were expressed as number and percentage and were compared using the Fisher exact and Kruskal-Wallis tests. Continuous variables were expressed as mean±standard deviation and compared using the unpaired t-test. The Kaplan-Meier method was used to analyze overall survival and major adverse cardiovascular and cerebrovascular disease (MACCE)-free survival. Multivariate analyses were performed using logistic regression, and p-values \<0.05 were considered to indicate statistical significance. We used IBM SPSS ver. 25.0 for Windows (IBM Corp., Armonk, NY, USA) for the statistical analysis.

Results
=======

Patient characteristics and early clinical outcomes
---------------------------------------------------

Among the 160 patients included in the study, 90 (56.3%), 39 (24.4%) and 31 (19.4%) patients were classified into groups 1, 2, and 3, respectively. The preoperative data are listed in [Table 1](#T1){ref-type="table"}. The mean age of the patients was 64.9± 10.7 years, and there were no significant demographic and clinical differences between the 3 groups apart from the incidence of chronic renal failure (CRF) and peripheral vascular disease. Group 3 had the highest rates of CRF (48.4%, p\<0.001) and left main disease (83.9%). Group 2 had the highest rates of a preoperative history of myocardial infarction (28.2%), intra-aortic balloon pump insertion (12.8%), and peripheral vascular disease (31.6%).

Moreover, significant differences were observed in the operative characteristics of the 3 groups, as shown in [Table 2](#T2){ref-type="table"}. The number of anastomoses in total and in each coronary territory differed among groups. Group 1 had a clinically significantly greater number of anastomoses (3.8±0.9) than the other groups (2.6±1.0 in group 2 and 3.3±0.9 in group 3) (p\<0.001). All 3 deaths (1.9%) that occurred within 30 days postoperatively were of noncardiac origin, and all occurred in group 2. In-hospital mortality was also highest in group 2 at 12.5% (p\<0.011); among all patients, the cases of mortality included 2 cases of septic shock and 1 each of cardiac arrest, cardiogenic shock, and pulmonary hemorrhage. Early mortality and the occurrence of stroke differed significantly between groups ([Table 3](#T3){ref-type="table"}), with group 2 having the highest early mortality rate and group 3 having the highest rate of stroke.

Long-term survival
------------------

The overall 5-year survival rate was 82.6%, and the 5-year survival rates in groups 1, 2, and 3 were 86.7%, 80.1%, and 75.8%, respectively (p=0.076) ([Fig. 2](#F2){ref-type="fig"}). There were no statistically significant differences in survival rate among groups. MACCEs were defined as all-cause mortality, stroke, myocardial infarction, and target vessel revascularization. The overall 5-year MACCE-free survival rate was 75.9% (p=0.006); group 1 had the highest survival rate to a significant extent at 84.2%, group 2 had a rate of 68.2%, and group 3 had the lowest rate at 65.7% ([Fig. 3](#F3){ref-type="fig"}).

Graft patency
-------------

Graft failure was defined as total graft occlusion as shown on coronary CT angiography, according to the FitzGibbon grading system \[[@ref4]\]. We further categorized graft patency by the anastomosed coronary territory and by the type of conduit. [Table 4](#T4){ref-type="table"} demonstrates graft patency for each coronary territory. The total patency rates were 98.7%, 95.3%, and 83.6% for the LAD, left circumflex artery, and right coronary artery territories, respectively. Patency rates for the inflow graft, the secondary graft (anastomosed to the inflow graft), and the tertiary graft (anastomosed to the secondary graft) were 98.2%, 90.2%, and 80.4%, respectively at a mean interval of 29.9±31.1 months after CABG surgery ([Tables 4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}).

Discussion
==========

The current literature demonstrates the superiority of BITA over other types of conduits in patients undergoing CABG \[[@ref5]\]. These benefits include increased short- and long-term patency, freedom from arteriosclerosis, and a higher survival rate in patients undergoing revascularization of the left coronary system \[[@ref4],[@ref5]\]. Statistical adjustment has shown that graft configuration is not an independent predictor of repeat revascularization or mortality \[[@ref5]\]. Additionally, previous studies have revealed that no single BITA graft configuration is superior to the others in terms of mortality or the need for repeat revascularization, apart from clear evidence supporting the use of the LITA-to-LAD graft. The use of the RITA as a second bypass conduit was a natural technical extension from these data. However, no consensus currently supports BITA grafting, as not all BITA configurations are equally effective. Our study therefore aimed to investigate whether any particular configuration was advantageous in terms of clinical outcomes and to attempt to determine the influence of configuration on graft patency.

Group 1 consisted of patients who underwent a typical LITA *in situ* Y-composite graft using RITA with additional conduits. In the case of LITA-based *in situ* conduits, geometric factors such as graft tension or torsion may mitigate any advantage gained by using the RITA as a composite graft. However, the use of composite grafting does allow the left-sided vessels to be bypassed with the BITA, without requiring proximal anastomosis to the aorta, and provides less concern regarding vessel length. A Y-composite graft was constructed when the RITA was too short to reach the left coronary artery territory or when the left coronary artery territory could not be completely revascularized with bilateral *in situ* ITA grafts. Nonetheless, the modified Y-composite graft allowed for more anastomoses than the single *in situ* LITA graft. This explains why group 1 had the highest survival and patency rates; the total number of anastomoses was greater, yielding higher revascularization of the left coronary circulation ([Table 2](#T2){ref-type="table"}). Our adaptation of RITA as a composite graft to bypass either the right or the left coronary circulation after LITA-to-LAD anastomosis was in congruency with 2 previous large series \[[@ref6],[@ref7]\], and our results showed that this is likely the most effective bypass configuration.

Group 2 patients---those who underwent surgery using the LITA-based I-shaped RITA configuration---had the poorest clinical outcomes, with the highest 30-day mortality and in-hospital mortality rates. As mentioned earlier, this could have been due to underlying preoperative conditions unfavorable to revascularization as well as to vascular compromise. Whether the I-configuration itself was the paramount contributor to these poor outcomes is still undetermined. According to a previous mechanical study by Fan et al. \[[@ref8]\], which assessed the difference in intramural stresses between end-to-side and end-to-end anastomoses, the proliferative influence of increased compliance mismatch on suture-line intimal hyperplasia was greater in end-to-side than in end-to-end anastomoses. In the present study, the configuration used in group 2 was an I-shaped end-to-end anastomosis, first anastomosed to the left coronary circulation and then extending to the right coronary circulation. Intramural stress alone therefore cannot be the factor that induced intimal hyperplasia compromising vascular integrity; instead, the anastomosis to the distal branches of the RCA with the free RITA in a composite configuration may have resulted in flow competition or limited flow to secondary and tertiary sites. The longer the arterial configuration, the lower the pressure at the distal anastomosis \[[@ref9]\], and lower pressure in the distal portion of the Y branch may have compromised the distal anastomosis as well. However, the in-hospital and 30-day mortality rates in this group did not result from revascularization. The mortality cases were mostly of noncardiac origin, meaning that the high mortality rates in group 2 can be attributed to that group's preoperative risk factors and vascular compromise due to underlying medical conditions, rather than to the graft configuration. Preoperative intra-aortic balloon pump insertion, atrial fibrillation, and peripheral vascular disease likely led to vascular compromise and low cardiac function, which resulted in subsequent in-hospital mortality from causes such as cardiogenic shock and cardiac arrest \[[@ref10]\]. Nevertheless, this configuration may be assumed in selected patients, since the high mortality rate notwithstanding, overall 5-year survival and MACCE-free survival were higher than in group 3 ([Fig. 3](#F3){ref-type="fig"}).

Lastly, the configuration used in group 3 was a RITA-based composite graft. In this group, the RITA was generally anastomosed to the left coronary circulation first, and the distal end of the LITA was anastomosed to the distal branch of the RCA. As in group 2, anastomosing the distal branch with the free RITA in a composite configuration is associated with a risk of flow competition \[[@ref8]\], and due to the lower pressure in the distal portion of the I branch, competitive flow was more frequent at the right coronary bed than at the left. In addition, in accordance with a previous study by Glindeur et al. \[[@ref11]\], our study showed that grafting of the intermediate branch or of the distal RCA negatively impacted the prognosis of graft function and thus patency. Group 3 had lower 30-day mortality and in-hospital mortality rates than group 2. However, the patency, overall 5-year survival, and MACCE-free survival rates were lowest in group 3, which could be attributed to ineffective revascularization. The configuration used in this group may cause kinking of the intermediate anastomoses, especially if the proximal Y anastomoses were performed near the pulmonary artery, were inside the pericardium, or were compressed by the myocardium \[[@ref11],[@ref12]\]. Such secondary and tertiary sites had the lowest patency rates.

Although previous studies have shown no difference in long-term survival or freedom from repeat revascularization between different BITA configurations \[[@ref12]-[@ref20]\], and although those studies have also shown that no particular configuration is associated with relatively favorable clinical outcomes, our study revealed that certain aspects of the configuration must be considered. The selection of the ideal BITA configuration should be based on technical factors associated with the individual patient. The RITA-based composite graft showed the lowest patency rates in the distal RCA territory; thus, in patients in need of revascularization of the right coronary system, this configuration must be discouraged. In contrast, when possible, a LITA-based Y-composite graft should be performed, with the LITA-to-LAD graft serving as the gold standard (as in previous studies) because it is expected to yield successful revascularization and thus better clinical outcomes. In general, the technically simplest technique should be selected, as more complex configurations offer no additional benefit to patients. Further studies assessing the mechanical dynamics of graft configurations are necessary to provide clearer insight into relatively favorable configurations.

This study was limited by its retrospective nature. Graft patency could be evaluated shortly after surgery in only about 70% of patients, with most evaluations performed within 6 months to 2 years postoperatively. The long-term patency rate could not be uniformly assessed, and the method of patency evaluation was also inconsistent. Postoperative CT angiography and CAG were not previously designated in the postoperative patient groups, and the possibility of the imaging modality either overestimating or underestimating graft patency cannot be excluded. We also could not enroll all patients in imaging follow-up during a specific postoperative period, which may have affected the analysis of patency. Unquantifiable factors such as underlying comorbidities, the target vessel, and conduit quality could not be accounted for by risk adjustment. Additionally, this study did not investigate important clinical endpoints, such as recurrent myocardial infarction and repeat revascularization, which could reflect graft patency.

In conclusion, recent studies have shown that there is no difference in clinical outcomes between composite graft and *in situ* graft configurations and that BITA configuration does not affect mortality, graft patency, or the need for repeat revascularization. However, our study found that although atypical configurations were associated with relatively acceptable clinical outcomes and patency rates, the LITA-based Y-composite graft continues to be the gold standard graft configuration. Although the BITA composite configuration can be modified in response to unexpected intraoperative technical difficulties or limitations such as a short length or complex sequential anastomosis, a RITA-based composite graft should not be the first resort in patients in need of right coronary revascularization along with LAD revascularization. However, this does not mean that such a configuration must always be discouraged, because existing studies still advocate that no particular graft configuration is better than another, apart from LITA-to-LAD anastomoses. Patients requiring multivessel coronary surgery should be strongly considered for BITA grafting and revascularization, even with atypical configurations, when clinical factors permit.
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![Methods of modifications. Group 1: modification of a typical Y graft (n=90, 56.3%). (A) The short right internal thoracic artery was extended with the remaining LITA or an additional saphenous vein graft (n=65). (B) Twisted Y graft for LITA-left anterior descending artery mismatch (n=12). (C) Secondary Y graft (n=9). (D) Double Y or π graft (n=4). Group 2: LITA-based I composite graft (n=39, 24.4%). (E) LITA-based I graft to the LAD (n=32). (F) LITA-based I graft to an area other than the LAD (n=7). Group 3: RITA-based composite graft (n=31, 19.4%). (G, H) RITA-based I graft (n=25). (I) RITA-based reverse T or U graft (n=3). (J) RITA-based Y graft (n=3). LITA, left internal thoracic artery; LAD, left anterior descending artery; RITA, right internal thoracic artery.](KJTCV-53-064-f1){#F1}
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###### 

Preoperative characteristics of patients

  Characteristic                            Total        Group 1: modification of Y graft   Group 2: LITA-based I graft   Group 3: RITA-based graft   p-value
  ----------------------------------------- ------------ ---------------------------------- ----------------------------- --------------------------- ---------
  No. of patients                           160          90                                 39                            31                          
  Age (yr)                                  64.9±10.7    64.3±11.1                          65.5±11.0                     65.9±9.1                    0.924
  Sex (male)                                114 (71.3)   64 (71.1)                          28 (71.8)                     22 (71.0)                   0.996
  Smoker                                    83 (51.9)    46 (51.1)                          24 (61.5)                     13 (41.9)                   0.258
  Hypertension                              122 (76.3)   70 (77.8)                          30 (76.9)                     22 (71.0)                   0.740
  Diabetes mellitus                         98 (61.3)    57 (63.3)                          20 (51.3)                     21 (67.7)                   0.309
  Dyslipidemia                              60 (37.5)    38 (42.2)                          13 (33.3)                     9 (29.0)                    0.351
  Chronic renal failure                     29 (18.1)    9 (10.0)                           5 (12.8)                      15 (48.4)                   \<0.001
  Prior myocardial infarction                                                                                                                         
  Acute                                     43 (26.9)    27 (30.0)                          10 (25.6)                     6 (19.4)                    0.504
  Old                                       38 (23.8)    23 (25.6)                          11 (28.2)                     4 (12.9)                    0.272
  Coronary disease                                                                                                                                    
  1-Vessel disease                          1 (0.63)     1 (1.11)                           0                             0                           
  2-Vessel disease                          32 (20.3)    10 (11.1)                          17 (43.6)                     5 (16.1)                    
  3-Vessel disease                          125 (79.1)   79 (87.8)                          22 (56.4)                     26 (83.9)                   
  Left main disease                         35 (22.2)    16 (17.8)                          7 (17.9)                      12 (30.7)                   
  Prior stroke                              44 (27.5)    21 (23.3)                          12 (30.8)                     11 (35.5)                   0.371
  Chronic obstructive pulmonary disease     14 (8.8)     10 (11.1)                          2 (5.4)                       2 (6.5)                     0.513
  Atrial fibrillation                       11 (6.9)     5 (5.6)                            5 (12.8)                      1 (3.2)                     0.218
  Peripheral vascular disease               29 (18.1)    10 (11.4)                          12 (31.6)                     7 (22.6)                    0.022
  Left ventricular ejection fraction ≤40%   42 (26.3)    27 (30.0)                          9 (24.3)                      6 (19.4)                    0.481
  Preoperative intra-aortic balloon pump    16 (10.0)    8 (8.9)                            5 (12.8)                      3 (9.7)                     0.790

Values are presented as number, mean±standard deviation, or number (%).

LITA, left internal thoracic artery; RITA, right internal thoracic artery.

###### 

Operative data

  Variable                                                Total        Group 1: modification of Y graft   Group 2: LITA-based I graft   Grouup 3: RITA-based graft   p-value
  ------------------------------------------------------- ------------ ---------------------------------- ----------------------------- ---------------------------- ---------
  No. of patients                                         160          90                                 39                            31                           
  Surgical acuity                                                                                                                                                    
  Urgent                                                  38 (23.8)    23 (25.6)                          7 (17.9)                      8 (25.8)                     0.619
  Emergent                                                9 (5.6)      4 (4.4)                            3 (7.7)                       2 (6.5)                      0.647
  No. of anastomosis                                                                                                                                                 
  Total                                                   3.4±1.1      3.8±0.9                            2.6±1.0                       3.3±0.9                      \<0.001
  Left anterior descending artery                         1.0±0.2      1.0±0.1                            0.9±0.3                       0.9±0.2                      0.040
  Lateral[a)](#t2f3){ref-type="table-fn"}                 1.4±0.9      1.7±0.8                            0.7±0.8                       1.3±0.7                      \<0.001
  Right coronary artery[b)](#t2f3){ref-type="table-fn"}   1.1±0.5      1.1±0.5                            1.0±0.5                       1.1±0.6                      0.597
  Isolated CABG                                           135 (84.4)   82 (91.1)                          29 (74.4)                     24 (77.4)                    0.024
  Cardiopulmonary bypass status                                                                                                                                      
  Off-pump CABG                                           95 (59.4)    52 (57.8)                          21 (53.8)                     22 (71.0)                    0.314
  On-pump beating CABG                                    65 (40.6)    38 (42.2)                          18 (46.2)                     9 (29.0)                     0.314
  Conventional CABG                                       33 (20.6)    13 (14.4)                          13 (33.3)                     7 (22.6)                     0.049

Values are presented as number, number (%) or mean±standard deviation.

LITA, left internal thoracic artery; RITA, right internal thoracic artery; CABG, coronary artery bypass grafting.

^a)^Diagonal/Ramus/obtuse marginal artery. ^b)^Posterolateral branch/posterior descending artery.

###### 

Early clinical outcomes

  Variable                                                Total       Group 1: modification of Y graft   Group 2: LITA-based I graft   Group 3: RITA-based graft   p-value
  ------------------------------------------------------- ----------- ---------------------------------- ----------------------------- --------------------------- ---------
  No of patients                                          160         90                                 39                            31                          
  30-day mortality[a)](#t3f3){ref-type="table-fn"}        3 (1.9)     0                                  3 (7.7)                       0                           0.020
  In-hospital mortality[b)](#t3f3){ref-type="table-fn"}   8 (5.0)     1 (1.1)                            5 (12.8)                      2 (6.5)                     0.011
  Hospital stay (day)                                     12.6±15.5   12.4±16.0                          10.3±6.7                      16.1±21.1                   0.178
  Morbidity                                                                                                                                                        
  Reoperation for bleeding                                3 (1.9)     2 (2.2)                            1 (2.6)                       0                           1.000
  Stroke                                                  4 (2.5)     0                                  1 (2.6)                       3 (9.7)                     0.011
  Acute renal failure requiring dialysis                  2 (1.3)     0                                  2 (5.1)                       0                           0.095
  Respiratory complication                                6 (3.8)     1 (1.1)                            3 (7.7)                       2 (6.5)                     0.079
  Arrhythmia                                              5 (3.1)     3 (3.3)                            2 (5.1)                       0                           0.593
  Wound complication                                                                                                                                               
  Superficial wound infection                             5 (5.0)     4 (4.4)                            2 (5.1)                       2 (6.5)                     0.887
  Mediastinitis                                           4 (2.5)     2 (2.2)                            0                             2 (6.5)                     0.214

Values are presented as number, number (%) or mean±standard deviation.

LITA, left internal thoracic artery; RITA, right internal thoracic artery.

^a)^Acute respiratory distress syndrome (n=1), cerebral infarction (n=1), and bowel infarction (n=1). ^b)^Conditions listed above (n=3), septic shock (n=2), cardiac arrest (n=1), cardiogenic shock (n=1), and pulmonary hemorrhage (n=1).

###### 

Graft patency by coronary territory

  Territory          Total (n=116)    Modification of Y graft (n=67)   LITA-based I graft (n=29)   RITA-based graft (n=20)
  ------------------ ---------------- -------------------------------- --------------------------- -------------------------
  LAD (LAD/D)        98.7 (152/154)   100.0 (96/96)                    100.0 (33/33)               92.0 (23/25)
  LCX (RI/OM/dLCX)   95.3 (121/127)   98.9 (91/92)                     69.2 (9/13)                 95.5 (21/22)
  RCA (PDA/PLb)      83.6 (97/116)    88.2 (60/68)                     79.3 (23/29)                73.7 (14/19)

Values are presented as % (number).

LITA, left internal thoracic artery; RITA, right internal thoracic artery; LAD, left anterior descending artery; D, diagonal; LCX, left circumflex artery; RI, ramus intermedius artery; OM, obtuse marginal artery; dLCX, distal left circumflex artery; RCA, right coronary artery; PDA, posterior descending artery; PLb, posterolateral branch.

###### 

Graft patency by type of conduit

  Conduit            Total (n=116)    Modification of Y graft (n=67)   LITA-based I graft (n=29)   RITA-based graft (n=20)
  ------------------ ---------------- -------------------------------- --------------------------- -------------------------
  Inflow graft       98.2 (114/116)   98.5 (66/67)                     100 (29/29)                 95 (19/20)
  Secondary graft    90.2 (105/116)   95.5 (64/67)                     89.7 (26/29)                75 (15/20)
  Total occlusion    8                2                                3                           3
  Distal occlusion   3                1                                0                           2
  Tertiary graft     80.4 (66/82)     83.6 (51/61)                     70 (7/10)                   72.7 (8/11)

Values are presented as % (number) or number.

LITA, left internal thoracic artery; RITA, right internal thoracic artery.
